Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
738
-29
-4% -$9.14K 0.03% 397
2026
Q1
$252K Sell
767
-157
-17% -$56.4K 0.04% 368
2025
Q4
$325K Buy
924
+57
+7% +$20.8K 0.05% 272
2025
Q3
$321K Sell
867
-28
-3% -$10.8K 0.05% 237
2025
Q2
$354K Buy
895
+65
+8% +$24.3K 0.07% 192
2025
Q1
$309K Buy
830
+15
+2% +$5.71K 0.05% 196
2024
Q4
$293K Buy
815
+68
+9% +$25.2K 0.06% 184
2024
Q3
$270K Buy
747
+43
+6% +$14.8K 0.06% 183
2024
Q2
$240K Buy
704
+36
+5% +$12.2K 0.06% 174
2024
Q1
$239K Sell
668
-2
-0.3% -$673 0.07% 166
2023
Q4
$201K Buy
+670
New +$188K 0.06% 176

Other funds holding SYK

Optas LLC's SYK Position: Q2 2026 in Review

Optas LLC reduced its Stryker (SYK) stake by 3.8% in Q2 2026, selling an estimated $9.14K and leaving 738 shares worth $232K. The position accounts for 0.03% of the portfolio, ranked #397.

Optas LLC first reported a position in SYK in Q4 2023 and has held it in 11 quarters since. The position peaked at $354K in Q2 2025. 677 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Optas LLC held 738 shares of Stryker worth $232K as of Q2 2026.
  • Optas LLC sold 29 Stryker shares in Q2 2026, an estimated $9.14K.
  • Stryker made up 0.03% of Optas LLC's portfolio in Q2 2026, its #397 holding.
  • Optas LLC first reported a position in Stryker in Q4 2023 and has held it in 11 quarters since.
  • Optas LLC's Stryker position peaked at $354K in Q2 2025.
  • 677 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.